Paclitaxel and cisplatin chemotherapy for metastatic urothelial carcinoma after failure of two courses of platinum-based regimens
โ Scribed by Jae Young Joung; Whi-An Kwon; In-Chang Cho; Eun Kyung Kim; Sohee Park; Hyekyoung Yoon; Ho Kyung Seo; Jinsoo Chung; Weon Seo Park; Kang Hyun Lee
- Book ID
- 108980342
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 188 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0919-8172
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: A pilot study of a new chemotherapy, the civic regimen, was performed in 58 patients with metastatic breast carcinoma previously treated with chemotherapy with or without hormonal therapy (n = 41). cisplatin, 20 mg/m2/day, was given (days 1-5) every 21 days during a 1-hour intravenou
## Abstract ## BACKGROUND The authors attempted to determine the maximum tolerated dose (MTD) of gemcitabine in combination with etoposide and cisplatin as a chemotherapy regimen and investigated the safety and antitumor activity with the recommended doses of gemcitabine with etoposide and cisplat